Guangdong Ardent Biomed Co., Ltd.

GuangDong Ardent Biomed Co., Ltd is an American medical technology company, initially founded as a product development and research lab in Silicon Valley California in 2011. In 2016 ABIOM established its Product manufacturing and Marketing Center and genetic testing service center in Guangzhou High-Tech Industrial Development Zone, With strong R&D team, ABIOM has developed over 120 products and owns 100 patents, including more than 20 authorized invention patents and two PCT invention patents.

With the mission of "Health Brings Prosperity", ABIOM focuses on Precision medicine and is committed to becoming an innovation leader on accurate diagnosis in immune and infectious diseases that accounts for 66% of the trillion IVD market.

Our vision is to "ABIOM improves health" Ardent has developed the world's first leading Microfluidic HDL Subtyping System(with instrument and reagent kits), which improves the accurate detection and risk assessment of the world's number one killer cardiovascular disease(CVD) at a very early period(before the age of 45).

ABIOM genetic testing service center covers its testing services with four categories: Immune and Inflammatory Diseases, Infectious Diseases, Reproductive Health, and Cancer.

Guangdong Ardent Biomed Co., Ltd is one of the very few high-tech IVD enterprises in China that provides a one-stop service from R&D to production of raw materials (enzyme etc. ), reagent kits, medical consumables, instruments, as well as molecular diagnostic services, expert interpretation and health management services.


The company founder, Dr. David Deng, has more than 20-year experience of leading diagnostic product R& AMP; D in Silicon Valleys of three world-known public companies: Agilent Tech, Varinata, Illumina and Ion Torrent, Thermofisher.

Our main business:

Whole range of Nucleic Acid Extraction kit, disposal sampling kit, Nucleic Acid Detection Kit etc.

Reagent kits, devices

Molecular diagnostic testing services

Research services